Organic electroluminescent materials and devices

US10930864B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10930864-B2
Application numberUS-201815952817-A
CountryUS
Kind codeB2
Filing dateApr 13, 2018
Priority dateMay 10, 2017
Publication dateFeb 23, 2021
Grant dateFeb 23, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present invention includes novel metal complexes of 5H-benzimidazo[1,2-a]benzimidazole (“BimBim”) and related ligands. The novel ligands may coordinate to one or two metal centers. The metal complexes of the present invention comprising these ligands may be useful as emissive materials and n-dopants in OLED devices.

First claim

Opening claim text (preview).

We claim: 1. A compound having a formula selected from the group consisting of: wherein M 1 and M 2 are metal atoms; wherein X 1 -X 8 are each independently selected from group consisting of carbon and nitrogen; wherein Y is N, O, or S; wherein the dashed line (----) represents no bond to the maximum possible number of allowed bonds; wherein L 1 and L 2 are one or more ligands that are optionally attached to M 1 and M 2 , respectively; wherein when L 1 or L 2 are present, m or n has a value of at least one and is the maximum number of ligands L 1 and L 2 that may be attached to M 1 and M 2 , respectively; wherein L 1 and L 2 may be joined together to form a bridging ligand; wherein R 1 and R 2 each independently represent mono to the maximum possible number of substitutions, or no substitution; wherein each R 1 and R 2 is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; wherein any two adjacent R 1 or R 2 are optionally joined or fused to form a ring; and wherein p is an integer between 1 and 4. 2. The compound of claim 1 , wherein each R 1 and R 2 is independently selected from the group consisting of hydrogen, deuterium, fluorine, alkyl, cycloalkyl, heteroalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, aryl, heteroaryl, nitrile, isonitrile, and combinations thereof. 3. The compound of claim 1 , wherein M 1 and M 2 are each independently selected from the group consisting of Cr, Mo, W, Os, Ir, Pd, and Pt. 4. The compound of claim 1 , wherein M′ is the same as M 2 . 5. The compound of claim 1 , wherein M′ is different from M 2 . 6. The compound of claim 1 , wherein X 1 -X 8 are carbon. 7. The compound of claim 1 , wherein at least one of X 1 -X 8 is nitrogen. 8. The compound of claim 1 , wherein Y is N. 9. The compound of claim 1 , wherein L 1 and L 2 are each independently selected from the group consisting of: wherein each Y 1 to Y 13 are independently selected from the group consisting of carbon and nitrogen; wherein Y′ is selected from the group consisting of BR e , NR e , PR e , O, S, Se, C═O, S═O, SO 2 , CR e R f RR, SiR e R f , and GeR e R f ; wherein R e and R f are optionally fused or joined to form a ring; wherein each R a , R b , R e , and R d may independently represent from mono substitution to the maximum possible number of substitution, or no substitution; wherein each R a , R b , R e , R d , R e and R f is independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acid, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and wherein any two adjacent substituents of R a , R b , R c , and R d are optionally fused or joined to form a ring or form a multidentate ligand. 10. The compound of claim 9 , wherein L 1 and L 2 are each independently selected from the group consisting of: 11. The compound of claim 9 , wherein L 1 and L 2 are each independently selected from the group consisting of:

Assignees

Inventors

Classifications

  • containing organic luminescent materials · CPC title

  • Platinum compounds · CPC title

  • containing three nitrogen atoms as heteroatoms · CPC title

  • of the platinum group, i.e. Os, Ir, Pt, Ru, Rh or Pd · CPC title

  • Electricity · mapped topic

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10930864B2 cover?
The present invention includes novel metal complexes of 5H-benzimidazo[1,2-a]benzimidazole (“BimBim”) and related ligands. The novel ligands may coordinate to one or two metal centers. The metal complexes of the present invention comprising these ligands may be useful as emissive materials and n-dopants in OLED devices.
Who is the assignee on this patent?
Universal Display Corp
What technology area does this patent fall under?
Primary CPC classification C07F15/0086. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Feb 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).